IDYA - IDEAYA Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/2017
Total Revenue--
Cost of Revenue--
Gross Profit--
Operating Expenses
Research Development31,74912,384
Selling General and Administrative4,6682,054
Non Recurring--
Others--
Total Operating Expenses36,41714,438
Operating Income or Loss-36,417-14,438
Income from Continuing Operations
Total Other Income/Expenses Net2,0712,576
Earnings Before Interest and Taxes-36,417-14,438
Interest Expense--
Income Before Tax-34,346-11,862
Income Tax Expense--
Minority Interest--
Net Income From Continuing Ops-34,346-11,862
Non-recurring Events
Discontinued Operations--
Extraordinary Items--
Effect Of Accounting Changes--
Other Items--
Net Income
Net Income-34,346-11,862
Preferred Stock And Other Adjustments--
Net Income Applicable To Common Shares-34,346-11,862